Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

DESONIDE

DESONIDE

Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview DESONIDE is listed in Drugs@FDA under application 202470 (ANDA).

Marketing status: Prescription Active ingredient DESONIDE Form and strength GEL;TOPICAL - 0.05% Sponsor SENORES PHARMS Submission history Latest submission status date: 2020-05-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview DESONIDE is listed in Drugs@FDA under application 202470 (ANDA). Marketing status: Prescription Active ingredient DESONIDE Form and strength GEL;TOPICAL - 0.05% Sponsor SENORES PHARMS Submission history Latest submission status date: 2020-05-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.